"Establishing a Culture of Compliance Management Throughout the Group"

Jeil Pharma Holdings announced on the 3rd that it conducted legal training on contract practices and the Fair Trade Act for all its affiliated companies.


This training targeted team leaders of each department across all affiliates, including Jeil Pharma Holdings, Jeil Pharmaceutical, Jeil Health Science, and Onconic Therapeutics. The sessions were provided both online and offline, enabling employees to complete the training regardless of their work locations.


Jeil Pharma Holdings announced on the 3rd that it conducted legal training on contract practices and the Fair Trade Act for team leaders of each department across all its affiliates. Jeil Pharma Holdings

Jeil Pharma Holdings announced on the 3rd that it conducted legal training on contract practices and the Fair Trade Act for team leaders of each department across all its affiliates. Jeil Pharma Holdings

View original image

The program shared basic legal knowledge regarding overall contract work, focusing on contract tasks frequently encountered in actual work. This included the main types of contracts that require legal review, the scope of review, precautions during contract execution, and management of documents post-signing. It also addressed issues related to the Fair Trade Act that may arise during the process of contract execution and negotiation of transaction terms.


Jeil Pharma Holdings continues to offer such training to strengthen its company-wide compliance management system and to enhance compliance awareness among executives and employees.



Juhyun Lee, Head of Compliance Management at Jeil Pharma Holdings, said, "We will continue to provide practical legal training so that our employees can proactively recognize and respond to risks related to the Fair Trade Act that may occur during the contract process, thereby establishing a culture of compliance management throughout the group."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing